search

INFOGRAPHIC

How Real-World Data Clears the Path to Your Next Breakthrough

Download PDF

Bringing new treatments to market is a winding road – full of critical intersections, potential detours, and high-stakes decisions. With Inovalon’s Real-World Data (RWD) and team of experts as your co-pilot, you can clear roadblocks, speed up approvals, and drive impact – all while staying on course toward better patient outcomes.

Simple illustration of a blue rocket launching upward, with clouds of smoke at the base indicating liftoff—perfect for projects visualizing real-world data trends or dynamic progress.

Milestone 1

Fueling Smarter
Clinical Trial Design & Recruitment

Start strong, finish faster. Approximately 80% of clinical trials fail to meet their initial enrollment targets and timelines, leading to significant delays and increased costs.1 Integrating RWD can enhance patient recruitment strategies, potentially mitigating these challenges.

Illustration of a clock with blue lines trailing to the left, suggesting fast movement or the passage of time—ideal for representing real-world data trends. The clock shows the time at approximately 1:10.

Milestone 2

Speeding Up
Regulatory Approvals

No more speed bumps. RWD strengthens your submissions, reducing inefficiencies and accelerating approvals – so therapies reach patients faster and safer. A growing proportion of FDA approvals now incorporate real-world evidence (RWE) in their assessments, with data on safety and effectiveness directly influencing final decisions.2

A simple blue outline illustration of a balance scale with two uneven pans, one higher and one lower, symbolizing imbalance or inequality often seen in real-world data.

Milestone 3

Unlocking Market Access and Reimbursement

Once approvals are secured, the next stop is market access. But limited access remains a major challenge – 50% of products that missed first-year forecasts did so primarily due to market access barriers.3 RWD equips your teams with the evidence needed to drive more meaningful conversations with payers and stakeholders – helping you justify pricing, demonstrate value, and overcome reimbursement hurdles to expand patient access.

A simple blue line drawing of a mountain with a flag at the summit, representing achievement or reaching a goal, inspired by real-world data.

Milestone 4

Bridging Clinical Success to Real‑World Impact

Our HEOR solutions transform RWD into actionable evidence – proving cost-effectiveness, long-term outcomes, and care quality to shape policy and payer decisions.

A blue location pin icon above three angled lines, resembling a stylized map or navigation symbol on a light background, hints at navigating through real-world data.

Milestone 5

Driving Commercial Success With Data‑Driven Strategies

Navigate the market with precision. Today, 67% of drug launches fail to meet expectations, often due to a lack of deep customer insights and an inability to effectively differentiate in the market,4 highlighting the critical need for better data-driven strategies.

Simple line drawing of two hands shaking, symbolizing agreement, partnership, or cooperation based on real-world data, with blue outlines and minimal shading on the sleeves.

Milestone 6

Paving the Way for Value‑Based Care

The final stretch: proving long-term impact. Payers and providers demand evidence of real-world outcomes – and RWE delivers.

Our insights help you quantify treatment impact, secure outcome-based agreements, and align with the future of value-driven healthcare. With the right data, you can demonstrate not just clinical efficacy, but economic and patient-centered value – ensuring broader access, better reimbursement, and stronger partnerships.

A blue map pin icon with a white circle in the center, displaying the number 1 in bold dark blue text—perfect for marking real-world data points on a map.
A blue map location pin with a white circle in the center containing the number 2 in dark blue, symbolizing real-world data. A gray shadow appears below the pin.
A blue map pin icon with a white circle in the center displaying the number 3 in dark blue, positioned above a gray oval shadow, often used to represent real-world data points on a map.
A blue location pin icon with a white center displays the number 4 in dark blue, representing real-world data. A gray shadow appears below the pin.
A blue map pin icon with a white circle in the center displaying the number 5 in dark blue, representing real-world data, above a gray oval shadow.
A light blue map pin icon, inspired by real-world data, features a white circle in the center displaying the number 6 in dark blue. A small shadow appears beneath the pin.
A single dark blue, winding, wavy road with dashed white center lines, running vertically against a plain white background, evokes the unpredictable paths often revealed by real-world data.
A winding, zigzagging road with dashed white center lines—reminiscent of paths in real-world data—runs vertically along the left side of a white background.
A light blue map location pin icon, inspired by real-world data, features a circular hole in the center and is positioned above a small gray shadow on a plain white background.

Final Destination:

Better Patient Outcomes

At every turn in the pharmaceutical lifecycle, Inovalon’s Real-World Data is your guide – steering you toward smarter decisions, stronger partnerships, and improved patient outcomes.

With us as your co-pilot, you can drive success from start to finish.

Ready to Accelerate Your Journey?

Learn how Inovalon can help you navigate the road ahead.

Contact Us

Inovalon and design® and Inovalon® are trademarks of Inovalon, Inc.

Share